VIDEO: See how it works
For Virtual and Site-based Clincial Trials
TrialWire™ delivers screened eligible patients for decentralized and site-based studies with a focus on APC and US regions.
ACROSS ALL LANGUAGES
The Platform can recruit patients literally anywhere. With its advanced language options, sponsors can target local communities, countries and global patient populations all with a 24-hour start-up.
We have compiled the most common questions here so please review and contact us if you have any other questions.
Why doesn't TrialWire™ Platform need IRB/EC approval?
So unlike the typical trial advert which has condition/TA, age, medical status and more and a phone number and email – what people see with AI-Match is an invitation to search on the Platform for a study that’s right for them.
Why doesn't TrialWire™ Platform collect patient details and build databases of patients?
So unlike all other online recruitment companies, we never ask for ID information until we find a study for them, and only so we can send on to their chosen clinic – we are very clear we don’t keep their information which means more people join studies via TrialWire™ Platform.
Which QMS system does TrialWire use?
How many studies has TrialWire™ Platform recruited for?
What is the TrialWire™ Platform success rate?
- 78% of trial rescue studies are fully recruited within the time allocated.
- 92% of trials that start with TrialWire™ Platform from the beginning recruit successfully on time and budget.
Why doesn't TrialWire™ Platform need prior experience in a TA?
Each study starts with a patient persona and we collect as much data as possible about the type of people we are targeting. This informs our algorithms and AI-Match screener.
This means we can instantly recruit for rare diseases through to the more common metabolic and dermatological studies.
CONTACT US NOW
Not Found Your Answer? Just Ask Us!
Please ask your question here and we will get back to you in under 24 hours.